CPAY vs RNST: which is the better buy in 2026?
Corpay, Inc.
NYSE:CPAY
B2B payments compounder trading at 11.5x forward earnings while growing 25% and printing $2.1B free cash, the market still treats it like a gas card company.
Full CPAY analysisRenasant Corporation
NYSE:RNST
A Mississippi community bank just tripled its footprint through the First Bancshares deal, and the market is treating it like nothing changed.
Full RNST analysisFactor by factor
Get head-to-heads like this, free
Join the Alexandria e-letter for Compass verdicts, earnings intelligence, and the contrarian calls the crowd misses. Twice a week, no noise.
Free forever. Unsubscribe anytime. We never share your email.
Frequently asked questions
Is CPAY or RNST the better buy in 2026?
CPAY and RNST are neck and neck at 90/100 on the Compass right now. The better fit depends on which factors matter most to you.
How does Alexandria compare CPAY and RNST?
Each company is scored 1-100 on eight factors: revenue growth, profitability, valuation, momentum, theme purity, moat, catalysts, and market position. The Compass Score is the composite, and the comparison below shows where each name wins factor by factor.
Compass Scores are proprietary editorial research from publicly available data, not investment advice or a recommendation regarding any security. Rankings update weekly.